Americhem Acquires Noble Biomaterials, Expanding Its Global Footprint in Functional Additives and Advanced Materials
Acquisition accelerates Americhem’s growth in high-value polymer and fiber markets and strengthens commercial reach
Press Release Disclaimer: This is a press release distributed through the XPR Media network. It has not been independently verified by our newsroom.
Americhem, a global designer and manufacturer of custom polymer solutions, today announced the acquisition of Noble Biomaterials, an advanced materials company that specializes in antimicrobial and conductivity solutions for soft surface applications. The acquisition adds Noble Biomaterials’ differentiated technologies and deep specialization to Americhem’s broader global platform, strengthening Americhem’s ability to support customers from concept through scalable commercial production.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261027511851/en/
Noble Biomaterials provides proprietary materials technology for mission-critical applications across high-growth markets including apparel & textiles, healthcare, and aerospace & defense. Its flagship platforms, IONIC+®, X-STATIC®, and CIRCUITEX®, deliver advanced functional capabilities backed by U.S. manufacturing and a robust IP portfolio built over two decades. Noble Biomaterials’ antimicrobial, odor control, and conductive technologies strengthen Americhem’s position in fiber and polymer solutions to capture significant growth across healthcare and other high-demand markets.
“This is an exciting step forward for Americhem as we continue to invest in high-growth, high-demand markets,” said John Richard, Chief Executive Officer of Americhem. “Noble Biomaterials brings exceptional capabilities in antimicrobial solutions, strong commercial relationships and a reputation for quality that aligns with our values. We will be better positioned to deliver specialized solutions at a global scale as we make strategic investments to grow in healthcare and aerospace and defense. We are excited about what we can achieve with Noble Biomaterials for our customers around the world.”
“Americhem is the right partner for Noble Biomaterials’ next chapter, bringing complementary capabilities, global reach, scalable resources, and a customer-first culture that will drive lasting value,” said Joel Furey, Founder and Chief Commercial Officer of Noble Biomaterials. “Our proprietary materials and brands, such as IONIC+®, X-STATIC®, and CIRCUITEX®, will benefit from Americhem’s global scale and deep knowledge of polymer and fiber applications. I am proud of our team and excited about what Noble and Americhem will accomplish together.”
“We believe Noble Biomaterials is an exciting addition, and its technology and market focus align well with Americhem’s strategic direction,” said Kaitlyn Desai, Principal at PPC. “This acquisition reinforces our conviction in Americhem’s growth strategy and the strength of its capabilities, and we look forward to continuing to support Americhem’s ambition to be a global leader in specialized polymer and advanced materials solutions.”
About Americhem
Americhem is an innovative, technology-driven leader in the global polymer industry. Its foundation is built around delivering Performance, Solutions, and Trust through close collaboration with customers. All of the company’s products are backed by complete technical support that ensures quality, reliability, and value. Americhem operates nine manufacturing plants and maintains sales offices throughout the world. For more information, visit www.Americhem.com.
About Noble Biomaterials
Noble Biomaterials is an advanced materials company that engineers proprietary technology for mission-critical applications across consumer, aerospace & defense, and healthcare markets. Through its X-STATIC®, IONIC+®, and CIRCUITEX® technology platforms, Noble delivers odor elimination, infection prevention, EMI shielding, multispectral signature management, and smart fabric enablement, solving complex performance challenges where failure is not an option. Noble’s headquarters and manufacturing facilities are located in Scranton, PA.
For more information on Noble Biomaterials and to view the full range of fabric applications, please visit www.noblebiomaterials.com.
About PPC
PPC is a family-oriented investment firm that specializes in partnering with family-, founder- and management-owned companies in the manufactured products and services sectors. The firm’s differentiated investor base, which is anchored by family investors, allows for aligned decision-making, flexible transaction structures and a focus on achieving long-term business objectives.
View source version on businesswire.com: https://www.businesswire.com/news/home/20261027511851/en/
Media gallery
